Lung Cancer

Journal

Publication Venue For

  • Corrigendum to “Clinical outcomes of black vs. non-black patients with locally advanced non–small cell lung cancer” [Lung Cancer 114, (December 2017) 44–49] (S016950021730555X) (10.1016/j.lungcan.2017.10.016)).  116:105. 2018
  • Clinical outcomes of black vs. non-black patients with locally advanced non–small cell lung cancer.  114:44-49. 2017
  • Pilot phase II study of metronomic chemotherapy in combination with bevacizumab in patients with advanced non-squamous non-small cell lung cancer.  106:125-130. 2017
  • Trends in stereotactic body radiation therapy for stage I small cell lung cancer.  103:11-16. 2017
  • Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.  72:229-237. 2011
  • Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.  72:219-223. 2011
  • Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.  55:145-156. 2007
  • 227 RNA interference against Hec1 targets malignant mesothelioma (MM).  54:S55-S55. 2006
  • Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer.  47:9-15. 2005
  • Phase II study of docetaxel plus enoxaparin in chemotherapy-naive patients with metastatic non-small cell lung cancer: Preliminary results.  42:237-245. 2003
  • Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally advanced non-small cell lung cancer: Long-term follow-up of a phase I trial.  37:189-199. 2002
  • Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.  36:133-141. 2002
  • Postoperative adjuvant therapy for non-small cell lung cancer: a consensus report.  11. 1994
  • Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report.  11. 1994
  • International Standard Serial Number (issn)

  • 0169-5002
  • Electronic International Standard Serial Number (eissn)

  • 1872-8332